For iCarbonX, success is in the genes

China's youngest ever unicorn is working with tech giant Tencent and is building an international digital alliance with other companies in the healthcare space.

Founded by Wang Jun, a former chief executive and co-founder of genome sequencing giant Beijing Genomics Institute BGI, healthcare technology start-up iCarbonX intends to mine and interpret genomic data from at least one million Chinese people in the next five years.

Having raised more than $600 million from backers including Tencent and listed cell and gene engineering firms, iCarbonX became in April last year the youngest start-up to reach a $1 billion valuation. It is one of the only three healthcare unicorns in China after United Imaging Healthcare $5 billion and GuaHao $1.5 billion, according to CB Insights data,

“We picked partners that could...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222